TORNTPHARM - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Buy at 4,780 ₹ with a stop-loss order set at 4,650 ₹, targeting a profit of 150 ₹. Alternatively, place an exit level at 4,950 ₹ if the price continues to climb strongly. Overall, the stock presents a moderate opportunity given the strong momentum and volume, but careful risk management is crucial due to the high valuation and potential negative news impact.
✅ Positive
Strong recent earnings growth (PAT up 49% QoQ) is driving momentum, and the high volume of 4.9 million shares traded suggests significant interest today. The DMA crossover confirms an upward trend, adding to positive sentiment.
⚠️ Limitation
A very elevated P/E ratio of 88.8 compared to the industry average of 34.8 indicates a premium valuation, making the stock vulnerable to a correction if growth doesn't maintain its current pace. Furthermore, the Debt-to-Equity ratio of 1.69 suggests moderate leverage, which adds some risk, especially in a potentially volatile market environment.
📉 Company Negative News
The removal of key personnel from Torrent Pharma’s SMP panel – as reported by scanx.trade – could introduce uncertainty regarding potential contract renewals or approvals, although this is likely already priced into the stock.
🏭 Industry
The pharmaceutical sector is currently experiencing moderate gains driven by innovation and increasing healthcare spending; however, recent regulatory changes and patent expirations create ongoing volatility within many companies. Today’s session will be heavily influenced by broader market sentiment affecting pharma stocks.